<html>
<head>PUBMED IDs for EBAG9</head>
<body bgcolor='#C5F0F2'><h1>EBAG9</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9418891/'>Isolation of estrogen-responsive genes with a CpG island library.</a> January 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10873660/'>Promoter analysis and chromosomal mapping of human EBAG9 gene.</a> June 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11374862/'>Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.</a> May 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12054692/'>RCAS1 is associated with ductal breast cancer progression.</a> June 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12160478/'>A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.</a> August 6  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12845666/'>EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.</a> July 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12855262/'>EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation.</a> July 12  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15164121/'>Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.</a> May 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15231680/'>Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.</a> July 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15635093/'>EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin.</a> January 7  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15867365/'>Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.</a> May 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15904507/'>Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.</a> May 21  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19030177/'>EBAG9 is a tumor-promoting and prognostic factor for bladder cancer.</a> January 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20570965/'>Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells.</a> November 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21573489/'>Intracellular estrogen receptor-binding fragment-associated antigen 9 exerts in vivo tumor-promoting effects via its coiled-coil region.</a> September 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24119785/'>Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.</a> July 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25365482/'>EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes.</a> November 5  2014<br></body></html>
